United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

Publisher Name :
Date: 22-Nov-2016
No. of pages: 95
Inquire Before Buying

Notes:

Sales, means the sales volume of 23-Valent Pneumococcal Polysaccharide Vaccine

Revenue, means the sales value of 23-Valent Pneumococcal Polysaccharide Vaccine

This report studies sales (consumption) of 23-Valent Pneumococcal Polysaccharide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- MSD

- Sanofipasteur

- CDIBP

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Single Dose Vial

- Pre-filled Syringe

- Type III

Split by applications, this report focuses on sales, market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in each application, can be divided into

- For Children (2-10)

- For Person (10-64)

- For The old (=65)

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

Table of Contents
United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016
1 23-Valent Pneumococcal Polysaccharide Vaccine Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.2.3 Type III
1.3 Application of 23-Valent Pneumococcal Polysaccharide Vaccine
1.3.1 For Children (2-10)
1.3.2 For Person (10-64)
1.3.3 For The old (=65)
1.4 United States Market Size Sales (Value) and Revenue (Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2011-2021)
1.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Competition by Manufacturers
2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufactures (2015 and 2016)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
3.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) by Application (2011-2016)
4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Profiles/Analysis
5.1 MSD
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Sanofipasteur
5.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 CDIBP
5.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
6.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2016-2021)
10.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2016-2021)
10.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2016-2021)
10.4 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2015
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Table Application of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2015
Figure For Children (2-10) Examples
Figure For Person (10-64) Examples
Figure For The old (=65) Examples
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Figure 2016 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table 2016 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers in 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 Manufacturers
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Table MSD Basic Information List
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Sanofipasteur Basic Information List
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table CDIBP Basic Information List
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Forecast by Type (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2016-2021)
  • Global Encephalitis Vaccine Market Insights, Forecast to 2025
    Published: 17-Jan-2019        Price: US 3900 Onwards        Pages: 112
    Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds. It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas. The global Encephalitis Vaccine market is valued at xx million US$ in 2018......
  • Global Meningococcal Vaccines Market Research Report 2012-2024
    Published: 17-Jan-2019        Price: US 1800 Onwards        Pages: 74
    The global Meningococcal Vaccines market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global Meningococcal Conjugate Market Size, Status and Forecast 2019-2025
    Published: 15-Jan-2019        Price: US 3900 Onwards        Pages: 96
    Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. In 2018, the global Meningococcal Conjugate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.......
  • Global H1N1 Vaccines Market Insights, Forecast to 2025
    Published: 09-Jan-2019        Price: US 3900 Onwards        Pages: 117
    A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor ......
  • Global and Chinese Meningococcal Vaccines Industry, 2018 Market Research Report
    Published: 28-Dec-2018        Price: US 3000 Onwards        Pages: 138
    The 'Global and Chinese Meningococcal Vaccines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Meningococcal Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Meningococcal Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industr......
  • Global Influenza Vaccine Market Insights, Forecast to 2025
    Published: 27-Dec-2018        Price: US 3900 Onwards        Pages: 111
    Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. The global Influenza Vaccine market is valued at 3090 million US$ in 2018 and will reach 5270 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Influenza Vaccine marke......
  • Global Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2025
    Published: 25-Dec-2018        Price: US 3900 Onwards        Pages: 116
    Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age. The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. The global Pneumococcal Po......
  • Global Encephalitis Vaccination Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 25-Dec-2018        Price: US 3480 Onwards        Pages: 132
    Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. Scope of the Report: This report studies the Encephalitis Vaccination market status and ......
  • Global and Chinese H1N1 Vaccines Industry, 2018 Market Research Report
    Published: 17-Dec-2018        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese H1N1 Vaccines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global H1N1 Vaccines industry with a focus on the Chinese market. The report provides key statistics on the market status of the H1N1 Vaccines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs